JP2025528101A5 - - Google Patents

Info

Publication number
JP2025528101A5
JP2025528101A5 JP2025506960A JP2025506960A JP2025528101A5 JP 2025528101 A5 JP2025528101 A5 JP 2025528101A5 JP 2025506960 A JP2025506960 A JP 2025506960A JP 2025506960 A JP2025506960 A JP 2025506960A JP 2025528101 A5 JP2025528101 A5 JP 2025528101A5
Authority
JP
Japan
Prior art keywords
pair
domain
psr
polypeptide
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025506960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025528101A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/074836 external-priority patent/WO2024027120A1/en
Publication of JP2025528101A publication Critical patent/JP2025528101A/ja
Publication of JP2025528101A5 publication Critical patent/JP2025528101A5/ja
Pending legal-status Critical Current

Links

JP2025506960A 2022-08-05 2023-02-07 多重特異性ポリペプチド複合体 Pending JP2025528101A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2022/110697 2022-08-05
CN2022110697 2022-08-05
PCT/CN2023/074836 WO2024027120A1 (en) 2022-08-05 2023-02-07 Multi-specific polypeptide complexes

Publications (2)

Publication Number Publication Date
JP2025528101A JP2025528101A (ja) 2025-08-26
JP2025528101A5 true JP2025528101A5 (https=) 2026-02-17

Family

ID=89848477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025506960A Pending JP2025528101A (ja) 2022-08-05 2023-02-07 多重特異性ポリペプチド複合体

Country Status (6)

Country Link
EP (1) EP4565620A1 (https=)
JP (1) JP2025528101A (https=)
CN (1) CN119998329A (https=)
AU (1) AU2023318846A1 (https=)
CA (1) CA3263920A1 (https=)
WO (1) WO2024027120A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3177643B1 (en) * 2014-08-04 2019-05-08 F.Hoffmann-La Roche Ag Bispecific t cell activating antigen binding molecules
WO2017055392A1 (en) * 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Anti-cd3xcd44v6 bispecific t cell activating antigen binding molecules
WO2017055314A1 (en) * 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Bispecific anti-cd19xcd3 t cell activating antigen binding molecules
KR102692708B1 (ko) * 2016-12-20 2024-08-07 에프. 호프만-라 로슈 아게 항-cd20/항-cd3 이중특이성 항체 및 4-1bb(cd137) 작용물질의 병용 요법
CR20210330A (es) * 2018-12-21 2021-07-20 Hoffmann La Roche ANTICUERPOS QUE SE UNEN A CD3 (Divisional 2021-0325)
CA3124688A1 (en) * 2018-12-31 2020-07-09 Merus N.V. Truncated multivalent multimers
WO2020156405A1 (en) * 2019-01-28 2020-08-06 Wuxi Biologics (Shanghai) Co. Ltd. Novel bispecific cd3/cd20 polypeptide complexes
IL302412A (en) * 2020-11-06 2023-06-01 Novartis Ag Anti-CD19 and B-cell targeting agent combination therapy for the treatment of B-cell malignancies

Similar Documents

Publication Publication Date Title
AU2022218544B2 (en) Hetero-dimeric multi-specific antibody format
US12522654B2 (en) Engineered heterodimeric proteins
Brinkmann et al. The making of bispecific antibodies
US11286311B2 (en) CH3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof
JP6669722B2 (ja) Ｃｄ３結合ドメイン
TWI803876B (zh) 具有交叉結合區定向之雙重可變區類抗體結合蛋白
JP2025066715A (ja) 優先的な軽鎖の対合のために操作されたｃｈ１ドメインバリアント、およびそれを含む多重特異性抗体
US20040220388A1 (en) Novel heterodimeric fusion proteins
JP2022515424A (ja) 突然変異ｆａｂドメインを有する多重特異性結合タンパク質
CN107207592A (zh) 结构域交换的抗体
JP7734075B2 (ja) 疑似ｆａｂベースの多重特異性結合タンパク質
JP7826320B2 (ja) 二重または多重特異性抗体｛Ｂｉ ｏｒ Ｍｕｌｔｉ－Ｓｐｅｃｉｆｉｃ Ａｎｔｉｂｏｄｙ｝
JP2024517671A5 (https=)
JP2025528101A5 (https=)
CN115066275A (zh) 包含修饰的ehd2结构域的结合模块
WO2025162458A1 (zh) 融合抗体及其制备和应用
HK40107089A (zh) 位点特异性抗体缀合及其用途
HK40076734A (en) Composition of triax antibodies and method of making and using thereof